145 related articles for article (PubMed ID: 24117144)
21. Disproportionality methods for pharmacovigilance in longitudinal observational databases.
Zorych I; Madigan D; Ryan P; Bate A
Stat Methods Med Res; 2013 Feb; 22(1):39-56. PubMed ID: 21878461
[TBL] [Abstract][Full Text] [Related]
22. Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS).
Thurin NH; Lassalle R; Schuemie M; Pénichon M; Gagne JJ; Rassen JA; Benichou J; Weill A; Blin P; Moore N; Droz-Perroteau C
Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):890-903. PubMed ID: 32524701
[TBL] [Abstract][Full Text] [Related]
23. A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies.
Takeuchi Y; Shinozaki T; Matsuyama Y
BMC Med Res Methodol; 2018 Jan; 18(1):4. PubMed ID: 29310575
[TBL] [Abstract][Full Text] [Related]
24. Detecting potential safety issues in large clinical or observational trials by Bayesian screening when event counts arise from poisson distributions.
Gould AL
J Biopharm Stat; 2013; 23(4):829-47. PubMed ID: 23786257
[TBL] [Abstract][Full Text] [Related]
25. Evaluating heterogeneity in indoor and outdoor air pollution using land-use regression and constrained factor analysis.
Levy JI; Clougherty JE; Baxter LK; Houseman EA; Paciorek CJ;
Res Rep Health Eff Inst; 2010 Dec; (152):5-80; discussion 81-91. PubMed ID: 21409949
[TBL] [Abstract][Full Text] [Related]
26. The London low emission zone baseline study.
Kelly F; Armstrong B; Atkinson R; Anderson HR; Barratt B; Beevers S; Cook D; Green D; Derwent D; Mudway I; Wilkinson P;
Res Rep Health Eff Inst; 2011 Nov; (163):3-79. PubMed ID: 22315924
[TBL] [Abstract][Full Text] [Related]
27. Assessing performance of sequential analysis methods for active drug safety surveillance using observational data.
Zhou X; Bao W; Gaffney M; Shen R; Young S; Bate A
J Biopharm Stat; 2018; 28(4):668-681. PubMed ID: 29157113
[TBL] [Abstract][Full Text] [Related]
28. ConvSCCS: convolutional self-controlled case series model for lagged adverse event detection.
Morel M; Bacry E; Gaïffas S; Guilloux A; Leroy F
Biostatistics; 2020 Oct; 21(4):758-774. PubMed ID: 30851046
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions.
Gex-Fabry M; Balant-Gorgia AE; Balant LP
Drug Saf; 2001; 24(13):947-59. PubMed ID: 11735651
[TBL] [Abstract][Full Text] [Related]
30. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
31. Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study.
Iribarren C; Round AD; Peng JA; Lu M; Zaroff JG; Holve TJ; Prasad A; Stang P
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1222-32. PubMed ID: 23857878
[TBL] [Abstract][Full Text] [Related]
32. Part 5. Public health and air pollution in Asia (PAPA): a combined analysis of four studies of air pollution and mortality.
Wong CM; Vichit-Vadakan N; Vajanapoom N; Ostro B; Thach TQ; Chau PY; Chan EK; Chung RY; Ou CQ; Yang L; Peiris JS; Thomas GN; Lam TH; Wong TW; Hedley AJ; Kan H; Chen B; Zhao N; London SJ; Song G; Chen G; Zhang Y; Jiang L; Qian Z; He Q; Lin HM; Kong L; Zhou D; Liang S; Zhu Z; Liao D; Liu W; Bentley CM; Dan J; Wang B; Yang N; Xu S; Gong J; Wei H; Sun H; Qin Z;
Res Rep Health Eff Inst; 2010 Nov; (154):377-418. PubMed ID: 21446215
[TBL] [Abstract][Full Text] [Related]
33. Case-population studies in pharmacoepidemiology.
Capellà D; Pedrós C; Vidal X; Laporte JR
Drug Saf; 2002; 25(1):7-19. PubMed ID: 11820909
[TBL] [Abstract][Full Text] [Related]
34. Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug Reactions.
Backenroth D; Chase H; Friedman C; Wei Y
PLoS One; 2016; 11(10):e0164304. PubMed ID: 27716785
[TBL] [Abstract][Full Text] [Related]
35. Likelihood-Ratio-Test Methods for Drug Safety Signal Detection from Multiple Clinical Datasets.
Huang L; Zalkikar J; Tiwari R
Comput Math Methods Med; 2019; 2019():1526290. PubMed ID: 30915153
[TBL] [Abstract][Full Text] [Related]
36. Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children.
Asturias EJ; Contreras-Roldan IL; Ram M; Garcia-Melgar AJ; Morales-Oquendo V; Hartman K; Rauscher M; Moulton LH; Halsey NA
Vaccine; 2013 Dec; 31(49):5909-14. PubMed ID: 24055354
[TBL] [Abstract][Full Text] [Related]
37. Case-base methods for studying vaccination safety.
Saarela O; Hanley JA
Biometrics; 2015 Mar; 71(1):42-52. PubMed ID: 25223544
[TBL] [Abstract][Full Text] [Related]
38. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.
Baker MA; Nguyen M; Cole DV; Lee GM; Lieu TA
Vaccine; 2013 Dec; 31 Suppl 10():K98-112. PubMed ID: 24331080
[TBL] [Abstract][Full Text] [Related]
39. A modified self-controlled case series method to examine association between multidose vaccinations and death.
Kuhnert R; Hecker H; Poethko-Müller C; Schlaud M; Vennemann M; Whitaker HJ; Farrington CP
Stat Med; 2011 Mar; 30(6):666-77. PubMed ID: 21337361
[TBL] [Abstract][Full Text] [Related]
40. Drug safety data mining with a tree-based scan statistic.
Kulldorff M; Dashevsky I; Avery TR; Chan AK; Davis RL; Graham D; Platt R; Andrade SE; Boudreau D; Gunter MJ; Herrinton LJ; Pawloski PA; Raebel MA; Roblin D; Brown JS
Pharmacoepidemiol Drug Saf; 2013 May; 22(5):517-23. PubMed ID: 23512870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
